Class VI Partners (“Class VI”) is pleased to announce that MYOS Corp (“MYOS” or the “Company”), a bionutrition company and the maker of Fortetropin®-based muscle health products for animals and humans, has been acquired by PetIQ, Inc. (“PetIQ”), a leading pet health and wellness company and portfolio company of Bansk Group. Class VI served as the exclusive financial advisor to MYOS in this transaction.
“It was a privilege to represent the MYOS team, and what they accomplished on behalf of their shareholders was truly inspiring,” said Zach Solomon, Vice President at Class VI Partners. “Through every stage of this process, Joe, Casey, and Dante held firm to their convictions and to a clear, consistent message about what this company is and what it stands for. The MYOS brand is still in its early innings, and in PetIQ they’ve found a partner who genuinely believes in the good they do for pets and their owners, and who can open up the globe and new channels of distribution. We could not be more excited about what lies ahead for the Company, its employees, and the next chapter of MYOS.”
“When our shareholders and board asked why I chose Class VI, I told them I had three simple criteria: I wanted to genuinely enjoy working with the team and have fun, I wanted to work with honest, hardworking people, and I wanted a great outcome,” said Joe Mannello, CEO of MYOS Corp. “Class VI met my expectations on every front. They represented MYOS with integrity, told our story with conviction, and helped us achieve an outstanding outcome for our shareholders. Just as importantly, they made what is often a stressful process enjoyable.”
The acquisition positions MYOS for its next phase of growth. The transaction includes MYOS’s full Fortetropin®-based portfolio of muscle health products, spanning both consumer-facing supplements and veterinary-exclusive formulations, and PetIQ intends to continue marketing the products under the MYOS and Fortetropin® brand names while integrating them into its broader health and wellness portfolio.
For PetIQ, the acquisition unlocks entry into animal muscle health — a massively underserved and fast-growing category within pet health and wellness. As pet parents increasingly seek preventive solutions that support mobility, injury recovery, and long-term vitality rather than treatment after a problem arises, MYOS brings PetIQ the category’s leading clinically studied brand, a proprietary and patented ingredient technology, and more than a decade of relationships built alongside veterinarians. Combined with PetIQ’s world-class manufacturing, distribution, and presence across retail and veterinary channels, the partnership positions MYOS to reach a dramatically larger population of pets while strengthening PetIQ’s leadership in preventive pet health.
“The MYOS team built something unique: a category-defining product backed by real science, and a business anyone would be proud to have built,” said Alex Woolford, Director at Class VI Partners. “More than a decade of clinical research and real relationships with veterinarians gave MYOS credibility most companies don’t have, and that shows in the outcome. This was a great result for shareholders, employees who now have a much bigger platform to grow on, and PetIQ.”
Based in Cedar Knolls, New Jersey, MYOS Corp is a bionutrition company focused on the discovery, development, and commercialization of Fortetropin®, a proprietary, patented bioactive compound that supports muscle growth and preservation by modulating myostatin, the body’s natural regulator of muscle mass. Backed by more than a dozen clinical studies and a robust patent portfolio, MYOS has built a leading, clinically studied muscle health brand supporting mobility, injury recovery, and healthy aging for dogs, cats, and horses, while also serving the human nutrition segment.
The transaction closed on July 27, 2026. Davis Graham & Stubbs, LLP served as legal counsel to MYOS and Davis Polk & Wardwell LLP served as legal counsel to PetIQ.
For more information about this transaction, please contact Zach Solomon (zsolomon@classvipartners.com or 303.243.5646) or Alex Woolford (awoolford@classvipartners.com or 303.243.5615).
About PetIQ
PetIQ, Inc. is a leading pet health and wellness company that develops, manufactures, and distributes a diverse portfolio of high-quality branded health products for companion pets, including OTC flea & tick products, dental treats, and wellness and nutritional products. Its brands include PetArmor®, Capstar®, Nextstar®, Minties®, VetIQ®, and Rocco & Roxie®, supported by world-class manufacturing and distribution facilities in Omaha, Nebraska and Springville, Utah. PetIQ is a portfolio company of Bansk Group, a consumer-focused private investment firm with more than $5 billion under management. Learn more at https://www.petiq.com.
About Class VI Partners
Class VI provides middle-market investment banking services, including mergers and acquisitions advisory, corporate advisory, business valuation, and private capital raising services through its affiliate, Class VI Securities, LLC and Member FINRA. Class VI is also affiliated with and offers wealth management services through Class VI Family Office, LLC, a Registered Investment Advisor with the Securities & Exchange Commission.
Joe Mannello, CEO of MYOS Corp, is a client of Class VI Partners and is not being compensated for sharing their opinion and experience with the firm. Any compensation creates a conflict of interest. Comments by Joe Mannello may not be representative of any other person’s experience with the firm and are no guarantee of future performance or success.
Additional Disclosures
Investment advisory services offered through Class VI Partners’ affiliate Class VI Family Office, LLC, a Registered Investment Adviser with the U.S Securities and Exchange Commission. Class VI Partners offers investment banking and private securities transactions through its affiliate, Class VI Securities, LLC. Class VI Securities, LLC is a registered broker/dealer and member of the Financial Industry Regulatory Authority (FINRA). Class VI Pathfinder, LLC provides general business consulting to privately held businesses. Collectively these entities are referred to herein as “Class VI”.
Testimonials may not be representative of the experience of other customers. Any promotion, either via testimonial or endorsement, is unpaid (in cash or non-cash form) and does not guarantee future performance or success. We believe that all information provided is from credible and reliable sources. This information does not constitute advice or a recommendation or offer to sell or a solicitation to deal in any security or financial product. It is provided for information purposes only and on the understanding that the recipient has sufficient knowledge and experience to be able to understand and make their own evaluation of the proposals and services described herein, any risks associated therewith and any related legal, tax, accounting or other material considerations.